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Abstract
Background Bariatric surgery is the most effective treatment for patients with obesity and type 2 diabetes (T2DM), inducing
profound metabolic changes associated with improvements in glycaemic control. In spite of the recognition of the physiological
changes associated with bariatric surgery, what remains underappreciated is the patient experience of surgery to treat T2DM.
Objectives This study explored the patient experience with regard to motivations, expectations and outcomes, including remis-
sion and relapse of diabetes.
Methods An in-depth qualitative approach was adopted, encompassing semi-structured interviews with patients (n=17) living with
obesity and T2DMboth pre- and postsurgery. Interpretive thematic analysis identified emergent themes using a grounded approach.
Results Analysis revealed a number of themes throughout the interviewswhich includedmotivations and perceived benefits of surgery,
obesity stigma and its impact on self-worth as well as perceptions of remission or relapse and the implications for sense of control.
Conclusions The motivation for undergoing bariatric surgery was driven by health concerns, namely T2DM and the desire to
reduce the risk of developing diabetes-related complications. Patients highlighted social and self-stigmatisation associated with
obesity and T2DM, leading to feelings of shame and an inability to seek support from family or healthcare professionals.
Stigmatisation created a sense of failure and feeling of guilt for having T2DM. As a result, patients felt responsible for main-
taining disease remission postoperatively and regarded the need for medication as a sign of treatment failure.
Keywords Obesity . Bariatric surgery . Type 2 diabetesmellitus . Patient-centred care
Key Points
Research examining patient’s experience of bariatric surgery to treat
T2DM is lacking
Understanding motivation and expected benefits of surgery is required to
improve care
Patients experience stigma resulting in self-stigmatisation, shame and
guilt
Cessation of medication is viewed by patients as indicative of treatment
success
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Introduction
The treatment of type 2 diabetes (T2DM) remains one of the
most common indications for bariatric surgery given the rapid
normalisation of glucose homeostasis it induces [1, 2].
Although initially seen as a cure for T2DM, longer-term evi-
dence has tempered this enthusiasm, replacing this view with
a more realistic appreciation of bariatric surgery as a means of
disease control. Our understanding of obesity and T2DM as
chronic and progressive conditions suggests that the efficacy
of treatment reduces over time and a proportion of patients
may experience a relapse of diabetes.
Looking at outcomes in bariatric surgery, the focus is on
weight loss, BMI, duration of disease remission and improve-
ments in cardiovascular risk factors. While these are undoubt-
edly important metrics to consider, the experience of patients
undergoing bariatric surgery to treat obesity and T2DM is
often overlooked. It is widely understood that the desire to
treat T2DM is one of the main reasons patients with obesity
undergo bariatric surgery with most expecting disease remis-
sion. In spite of this, our insight into the patient experience,
perceptions of the diagnosis of T2DM, remission and relapse
is lacking, an understanding which is essential in delivering
patient-focused care.
The aim of this study was to gain insights into patients’
lived experience with obesity, T2DM and bariatric surgery
to inform the adoption of a patient-centred approach to
treatment.
Methods
This study employed an in-depth qualitative approach,
encompassing semi-structured interviews with patients
(n=17) living with obesity (BMI>30 kg/m2) and T2DM.
Each patient was interviewed once using a semi-structured
interview structure with open-ended questions focusing on
several different domains the authors felt were important to
understanding the lived experiences of patients with T2DM
and obesity including motivations for undergoing surgery and
perceptions of disease remission and relapse. Although the
duration of the individual interview varied, a standardised
format was followed to ensure all patients were asked the
same questions. All interviews were carried out in English
which was the first language of the interviewer and all partic-
ipants. Interviews were conducted by the same person to limit
variability in how they were conducted. Themes explored
during the interviews included motivations for undergoing
surgery, personal and social implications of living with obe-
sity and T2DM and perceptions of diabetes remission and
relapse. Phenomenological analysis was employed which is
an approach to interpreting qualitative data whereby the re-
searcher aims to capture the experience of several individuals
through a reflective examination of their account or story [3,
4]. Thematic analysis involving critical review and coding of
transcripts to identify common themes amongst responses was
also carried out [5].
Participant Recruitment
Selection criteria required a diagnosis of T2DM according to
the ADA criteria, BMI >30 kg/m2 and that participants were
awaiting or had already undergone bariatric surgery. Ethical
approval was granted (HS-20-12-McGillicuddy). Purposive
sampling was employed, identifying patients who would pro-
vide information-rich cases as well those able to communicate
in a reflective manner [6]. Potential participants were in-
formed that care would be in no way affected and they could
withdraw at any point. The interviewer was not involved in
the care of the participants at any point.
Sample Size
There are no clear statistics-based rules for determination of
sample size within qualitative research and the number tends
to be deliberately limited in order to allow a focus on in-depth
analysis in order to synthesise common themes and messages
from a number of sources into a cohesive message [7]. This
approach is supported by qualitative research methodologists
who have suggested that the more information-rich data is
collected from each person, the fewer participants are needed
[8]. Moreover, sample sizes should be large enough to allow
for an understanding of the phenomenon under investigation
while also being small enough to allow for deep case-oriented
analysis [9].
Interview Structure
A semi-structured interview was employed, focusing on do-
mains important to understanding the lived experiences of
patients with T2DM and obesity. Interviews were conducted
over the phone and digitally recorded.
Analysis
A phenomenological approach to analysis was used with com-
mon themes identified to capture an overall understanding of
the experience. Using an interpretive thematic approach re-
quired coding transcripts, identifying important issues which
were indexed as they related to a theme. Specific statements
were analysed and categorised into themes which related to
the phenomenon being investigated [3]. Once themes were
identified, transcripts were re-analysed to identify quotes
which could be used for illustrative purposes [10].
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Results
Participant Characteristics
Thirty-two patients met the eligibility requirements of which,
and 17 agreed to participate (M=9, F=8). Fifteen (88%) had
already undergone bariatric surgery of which 12 (80%)
underwent RYGB and the remaining 3 had SG. Further pa-
tient characteristics can be found in Table 1.
Analysis
Analysis of the transcripts identified three important themes:
1. Motivation and perceived benefits of undergoing bariatric
surgery
2. Implications of disease on self-worth, stigmatisation and
psychosocial response
3. Perceptions of disease remission, relapse and control
Further analysis identified subthemes related to the major
themes seen in Table 2.
Motivation and Perceived Benefits
of Undergoing Bariatric Surgery
The main motivating factor for patients undergoing bariatric
surgery was the diagnosis of T2DM. Although nearly all of
the patients felt having T2DMnegatively affected their quality
of life, most felt this was secondary to concerns regarding the
development of diabetes-related complications. Many felt
without surgery, it was only a matter of time before compli-
cations manifested themselves.
I was very worried about my eyesight. I could lose my
job if I had eyesight problems. I also knew people that
lost toes and that really frightened me. (Richard, 40)
In addition to concerns about future health issues, many felt
there was an imminent threat to their lives, adding a sense of
urgency about undergoing bariatric.
I was getting really nervous about being so big because
at that point, I was 150 kg. I was thinking if I don’t do
something now to get this weight off, I could go with a
heart attack tomorrow. (Michael, 42)
Most felt taking insulin would mark a deterioration in dia-
betes control. In those already taking insulin or patients where
it had been considered, it intensified concerns regarding the
impact of T2DM. Additionally, it prompted a reconsideration
of bariatric surgery which some regarded as risky or extreme.
The diabetes was getting worse and they were saying
about having take insulin. I just refused. I wasn’t going
Table 1 Patient characteristics
Age (median) 49 (SD=9.42)
Median preoperative BMI (kg/m2) 44.4 (SD=4.82)
Procedure performed (n=15) RYGB= 80% (12)
SG= 20% (3)
Preoperative treatment Oral medication= 53%
Oral medication + insulin= 47%
Postoperative treatment Oral medication= 33.3%
Oral medication + insulin= 0
No medication=66.6%
BMI, body mass index; SD, standard deviation
Table 2 Main identified themes
and related subthemes Motivation and perceived benefit • Fear
• Functional limitation
• Impact on family
• Disease progression
• Prevention of complications





• Personal responsibility for illness
Perceptions of disease remission, relapse and control • Surgery to control disease process
• Personal control over maintenance of remission
• Self-efficacy
• Cessation of medications
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down that road with insulin. Because of that I thought
I’d take my chance on something more extreme like an
operation. (Kevin, 68)
Patients also considered surgery due to limitations in
performing activities of daily living, low energy levels and
physical pain which they hoped would improve.
I’ve got a son who is only 15 and a daughter who is 13. I
realised I’ve never even played football with them.
They’d only seen me huffing and puffing around the
house because I was constantly so tired so that was a
wake-up call. (Harry, 42)
Patients consistently expressed a fear of developing com-
plications of diabetes as well as limitations regarding their
ability to engage in activities of daily living as their primary
motivation for undergoing surgery. The possibility of requir-
ing insulin prompted patients to re-think the seriousness of
their illness, a finding in keeping with studies demonstrating
insulin use being seen as indicative of treatment failure and
disease progression [11].
Implications of Obesity and T2DM on Sense
of Self-worth, Stigmatisation
and Psychosocial Response
Patients frequently gave examples of overt and implied social
stigmatisation relating to obesity, affecting their sense of self-
worth. Participants felt others made assumptions or judge-
ments based on weight alone and the implication being that
obesity was the result of personal failings.
My biggest concern is what people think when they look
at you. They think you’re somebody who is lazy or
unable to control themselves or to self-indulgent, which
may or may not be true. But it’s all decided by my
physical appearance. (Grant, 46)
Experiences in the workplace were cited as examples of
how obesity was often seen to define them as a person, mak-
ing them a target for personal attacks.
I know that there are certain people that if I was told by
somebody something at work and I questioned it, they
would walk away and call me a fat cow. Because that’s
how they see me. They think I have nothing other than
that to offer. And people don’t consider being
overweight, anything other than something you’ve cho-
sen for yourself. (Marion, 48)
Patients also felt that their diagnosis of T2DM was seen by
others as the result of personal failings.
If you’ve got type two diabetes, if you’ve had a heart
attack or you’re overweight, people say....well you
know you do to yourself, so no help should be there
for you. You’re overweight so you sort it. (Ann, 49)
In addition to judgement as a result of having obesity
and T2DM, patients appeared to internalise these messages
and ultimately came to agree with them, resulting in shame
with regard to their diagnosis and decision to undergo
surgery.
I still am not happy about surgery and I’m not happy it’s
a solution. I think it’s nuclear really in the scheme of
things. And to be perfectly honest, I think it’s shameful
as well. (Mike, 42)
Messages of blame and failure were deeply ingrained and
firmly held. Even when presented with information to the
contrary, many still felt having T2DM was due to a personal
failing.
I absolutely feel responsible. And I’ve had this conver-
sation with the doctor a number of times when he pre-
sents research and tells me the scientific perspective but
I also know that if I eat better, exercisemore andmanage
myself better, I would not be like this. I ultimately I
make poor decisions. (Mike, 42)
Because of stigmatisation and self-blame, many patients
attempted to hide their diagnosis of T2DM.
I don’t tell anyone, not even my parents know. People
would certainly imply it’s my fault so it’s only my phar-
macist and doctor who knows but outside the medical
profession, nobody knows. (Bruce, 61)
Responses illustrated that obesity stigma remains one of
the remaining socially acceptable forms of discrimination
and is widespread. Although most participants recognise the
multifactorial causes for the development of obesity, many
have a firmly held belief that obesity is the result of personal
failings.
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Patient Perception of Disease Remission,
Relapse and Control
Patients held a paradoxical perception of their sense of control
with regard to obesity and diabetes. Most believed bariatric
surgery had become the only treatment option available hav-
ing felt unable to maintain long-term weight control despite
adherence to medical advice.
The weight was going up and nomatter what, I just can’t
seem to get control of it. Every time I tried to lose weight
it was just it was coming back bigger and bigger than
before. I felt I couldn’t control my weight or my diabe-
tes. (Catherine, 45)
Moreover, they felt this differentiated them from peers
without obesity who appeared to have control over their
weight, producing a sense of frustration and hopelessness.
I have battled every day in my head and my all my life
about my weight. I have thought, I am doing everything I can
and why am I here? Why do I have to do so much more than
my sister and my friends to lose weight? (Sarah, 46)
Regarding T2DM, patients expressed an inability to main-
tain glycaemic control, again despite adherence to dietary ad-
vice and pharmacotherapy. Even patients who had lost weight,
some reported glycaemic control continuing to worsen.
For the first few years, you carried on taking more met-
formin. And then when I started losing weight because
I’d been more mindful I suppose by then, the damage
had been done. Every check-up was a wee bit stronger
and there was talk of insulin. As the years went on and
even though the weight went down, the blood sugars
just kept going up and up. (Rachel, 48)
Although most expressed the sense they lacked control
with regard to weight loss maintenance or glycaemic control,
many felt the diagnosis of obesity and T2DM were their re-
sponsibility. This perception extended to the postoperative
period whereby patients felt remission of T2DM was their
responsibility and relapse would only occur due to a lack of
adherence. Rather than viewing weight loss maintenance and
diabetes control as an impossibility as it had been preopera-
tively, patients felt empowered and were confident in their
ability to maintain control of weight and T2DM in the long
term.
I don’t let myself think of relapse because ofmy lifestyle
changes that are in place, that will never be an issue.
(Andy, 51)
Patient perceptions of disease control or cure often equated
to the cessation of all medications. Either all medications were
stopped, and surgery was viewed as successful or they were
continued/restarted in which case, the procedure had failed,
even if glycaemic control had improved. In other words, suc-
cess was measured in the discontinuation of medications rath-
er than an improvement in glycaemia.
I would say restarting medications would be disastrous
because it’s the primary purpose for doing this. (David,
46)
Most believed relapse would be solely due to personal fail-
ings rather than physiological processes. As an extension,
many discussed the shame and disappointment they would
feel if they experienced a relapse of T2DM or needed
medication.
I’d be highly disappointed restarting medications but
more feeling like I disappointed myself. Not the surgery
was disappointing. (Ed, 51)
In addition to feeling personally responsible for maintain-
ing remission of T2DM, many felt others would see it as being
within their control to prevent relapse.
If my diabetes came back, it would be like an alcoholic
drinking after a liver transplant. People would certainly judge
you for not making the most of the surgery. (Maxwell, 49).
The perception of responsibility was clearly complicated
with patients feeling a sense of a being unable to control their
obesity or T2DM preoperatively followed by a sense of com-
plete responsibility for maintenance of disease remission in
the postoperative period.
Discussion
Three interconnected but distinct themes emerged which were
motivations and perceived benefits of bariatric surgery, impli-
cations of obesity and T2DM on sense of self-worth, stigma
and psychosocial response and perception of disease remis-
sion, relapse and control.
Patients consistently reported their primary goal in under-
going bariatric surgery was to reduce their risk of developing
diabetes-related complications. This finding is in keeping with
previous studies demonstrating the decision to undergo bar-
iatric surgery was driven by health concerns, independent of
the degree of obesity and patients with T2DM were more
likely to request surgery [12, 13]. Considering insulin use,
patients not only viewed it as a sign of disease progression
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but one which marked a turning point, prompting a reconsid-
eration of bariatric surgery.
Within many cultures, obesity is unfairly viewed as being
the result of gluttony, lack of restraint and ultimately, personal
failure. Conversely, prevention or disease treatment is
achieved through moral fortitude and will power, requiring
patients to eat less and exercise more. The biological plausi-
bility of this approach combined with the observation most
patients can achieve short-termweight loss neglects the reason
why it is not an effective treatment for obesity. The challenge
facing patients with obesity is not weight loss, rather weight
loss maintenance. As a result, many feel those with obesity
bear a personal responsibility and stigma is widespread, af-
fecting patients in education, employment, healthcare and in-
terpersonal relationships [14]. Experiences of stigma were
common amongst participants and many internalised these
messages resulting in self-stigmatisation, a process whereby
individuals become aware of a stereotype, come to agree with
it and ultimately, apply it to themselves resulting in reduced
self-worth and self-efficacy. The implications of self-stigma
were apparent with a widespread sense that weight and T2DM
were beyond their control. Particularly with regard to T2DM,
patients found even with weight loss and medical therapy,
glycaemic control remained poor or even worsened. Despite
feeling this was beyond their control, most continued to view
this as a personal failure. Conversely, in the postoperative
period, patients felt surgery had restored their sense of self-
determination having previously felt helpless, burdened by a
disease over which they felt they had no control. Although
patients were aware of the possibility of disease relapse, none
acknowledged it could be the result of disease progression or
physiological factors rather than personal failing.
With any operation, it is essential both patient and surgeon
agree regarding the aim of treatment. Studies suggest there is
often a discord within bariatric surgery with differences in the
priorities of patients compared to the surgeon negatively
impacting patient perception of outcomes [15]. Participants
consistently reported fears regarding imminent and long-
term implications of T2DM and as such, this was consistently
cited as a primary motivation for undergoing surgery.
Although this is in concordance with the surgeon’s aim of
treating T2DM to reduce the risk of developing diabetes-
related complications, a dichotomy arises when one considers
how each group quantifies or measures the success of surgery.
From the patient perspective, poor diabetes control is evi-
denced by the need to take medications; thus, the continuation
or the reintroduction of medication equates to the apparent
failure of bariatric surgery as a means to control T2DM.
This perception was evident in the responses of participants
who suggested that the success of their surgery was reflected
by the reduction or stoppage of medications. In spite of this,
patients who remained on medications did acknowledge that
although they were still taking medications, surgery had
improved their glycaemic control and felt they had achieved
their overall aim of reducing their risk of developing diabetes-
related complication. The importance patients place on medi-
cation cessation as a surrogate marker of success stands in
contrast to the point of view of the surgeon or physician,
whereby a suboptimal surgical outcome is evidenced by on-
going poor diabetes control, quantified by measures of
glycaemia. Given the mounting evidence supporting multi-
modal care, combining bariatric surgery with medications
for long-term disease control, it is important to be mindful of
this commonly held patient perception [16]. The way in which
surgeons frame the goals of surgery has implications for pa-
tient willingness to accept further treatment such as pharma-
cotherapy to improve postoperative glycaemic control.
Although this study has limitations which should be
recognised including the inability to conduct face to face in-
terviews due to the COVID-19 pandemic and the potential
lack of ethnic diversity in the population sampled given par-
ticipants were drawn from only one country, it provides crit-
ical insight into the patient lived experience of undergoing
bariatric surgery for T2DM, a previously unexplored topic.
Additionally, given the use of a purposive sampling strategy
to identify potential participants, there is the possibility of
introducing a selection bias; however, patients were invited
to participate based on their perceived willingness and ability
to engage with the interview process, irrespective of their ex-
perience with the process of undergoing bariatric surgery,
both positive and negative.
Conclusions
An understanding of the motivations and experiences of pa-
tients undergoing bariatric surgery for the treatment of T2DM
will help clinicians and patients align their goals and expecta-
tions, ultimately improving outcomes and the delivery of
patient-focused care.
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